Polish Registry of Percutaneous Coronary Intervention for Chronic Total Occlusions
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorNational Institute of Cardiology, Warsaw, Poland
About this trial
The goal of this observational study is to evaluate the safety, efficacy, and clinical outcomes of percutaneous coronary intervention (PCI) for chronic total occlusions (CTO) in patients treated in contemporary clinical practice in Poland.
The main questions it aims to answer are:
* What are the rates of procedural success and periprocedural complications of CTO PCI in routine clinical practice? * How do CTO PCI strategies and techniques, intravascular imaging, different treatment strategies, and mechanical circulatory support affect clinical outcomes? * How do clinical outcomes differ among different patient subgroups? * Can artificial intelligence-based analysis predict clinical and quality-of-life outcomes after CTO PCI?
Patients undergoing CTO PCI as part of their standard medical care will be prospectively enrolled in a national, multicenter registry, with clinical, procedural, and follow-up data collected to evaluate real-world outcomes.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients undergoing CTO PCI based on clinical grounds
Disqualifiers
Age <18 years
Patient's refusal to participate in the registry
Trial population
Consecutive patients undergoing CTO PCI at participating centers.
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
No trial groups listed
Trial outcomes
Primary outcomes
1
Technical success
Achievement of Thrombolysis In Myocardial Infarction grade 3 flow in all ≥2.5-mm distal branches with \<30% residual stenosis.
Time frame
procedural (1 day)Secondary outcomes
1
Total procedure time
Total procedure time in minutes.
Time frame
procedural (1 day)2
Fluoroscopy time
Fluoroscopy time in minutes.
Time frame
procedural (1 day)3
Radiation dose
Total radiation dose in Gy and uGycm2.
Time frame
procedural (1 day)4
Contrast volume
Total contrast volume in mL.
Time frame
procedural (1 day)Sponsors and contacts
Click on the lead sponsor to view all of their trials.
National Institute of Cardiology, Warsaw, Poland
Lead sponsor
Polish Cardiac Society
Collaborator
Source ClinicalTrials.gov